You have 9 free searches left this month | for more free features.

Carcinoma, Non-Small-Cell Lung

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metabolic Response to Food in Advanced Lung Cancer

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Weight loss (%)
  • (no location specified)
Jun 30, 2023

Learn About Dacomitnib in Non-small Cell Lung Cancer Which Has

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Oct 4, 2023

Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Self-administered survey at hospital
  • +2 more
  • (no location specified)
Oct 3, 2023

Carcinoma, Non-Small Cell Lung Trial in Zhengzhou (BAI combine with DEB-BACE)

Not yet recruiting
  • Carcinoma, Non-Small Cell Lung
  • BAI combine with DEB-BACE
  • Zhengzhou, Henan, China
    Gang Wu
Nov 7, 2023

NSCLC Trial (SGN-B6A, docetaxel)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 21, 2023

NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sugemalimab and Chemotherapy
  • Changsha, China
    Hunan Cancer Hospital
Jul 7, 2023

NSCLC Trial (KB-GDT-01)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • KB-GDT-01
  • (no location specified)
Sep 29, 2023

NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Wuhan, Hubei, China
    Qian Chu
Aug 18, 2023

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    Specific Protein Overexpression in Adult Non-Small Cell Lung

    Not yet recruiting
    • Non Small Cell Lung Cancer
      • (no location specified)
      Sep 29, 2023

      QOL After SURGERY and ADJUVANT Treatment

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Quality of Life
      • Questionnaires
      • Salamanca, Spain
        Hospital Clínico Universitario
      Oct 30, 2023

      Carcinoma, Non-small-Cell Lung Trial in New York, Fairfax (JNJ-86974680, Cetrelimab, Radiation Therapy)

      Recruiting
      • Carcinoma, Non-small-Cell Lung
      • New York, New York
      • +1 more
      Nov 8, 2023

      Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
        • (no location specified)
        Apr 21, 2023

        NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • +2 more
        • Nintedanib, gefitinib, erlotinib, afatinib
        • (no location specified)
        Oct 2, 2023

        Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

        Not yet recruiting
        • Stage II-IIIB(N2) Non-small Cell Lung Cancer
        • Shanghai, Shanghai, China
          Shanghai Pulmonary Hospital
        Oct 26, 2023

        Stage IB Non-small Cell Lung Cancer

        Completed
        • Stage IB Non-Small Cell Lung Carcinoma
          • Shanghai, China
            180 Fenglin Road
          Jul 29, 2023

          Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

          Not yet recruiting
          • Colorectal Neoplasms
          • +5 more
          • (no location specified)
          Nov 9, 2023

          Double-dose Furmonertinib in Treatment of Slow

          Not yet recruiting
          • Non Small Cell Lung Cancer
          • +3 more
          • (no location specified)
          Oct 31, 2023

          NSCLC Trial in Beijing

          Recruiting
          • NSCLC
            • Beijing, China
              Yuyan Wang
            Oct 10, 2023

            Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

            Not yet recruiting
            • Metastatic Lung Non-Small Cell Carcinoma
            • +2 more
            • Cetuximab
            • +2 more
            • Sacramento, California
              University of California Davis Comprehensive Cancer Center
            Oct 2, 2023

            NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

            Not yet recruiting
            • Carcinoma, Non-Small-Cell Lung
            • (no location specified)
            Nov 7, 2023

            NSCLC Trial in Chongqing (procedure, drug, radiation)

            Not yet recruiting
            • Carcinoma, Non-Small-Cell Lung
            • bronchial artery interventional therapy
            • +3 more
            • Chongqing, Chongqing, China
              Daping Hospital, Third Military Medical University
            May 27, 2023

            Integrative Multi-Omics Testing for Immunotherapy Response in

            Recruiting
            • Lung Cancer
              • Guangzhou, Guangdong, China
                Nanfang hospital
              Jun 29, 2023

              NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

              Not yet recruiting
              • Non-small Cell Lung Cancer
              • Iowa City, Iowa
                University of Iowa
              Oct 10, 2023

              NSCLC Trial in Shanghai

              Not yet recruiting
              • Non-small Cell Lung Cancer
                • Shanghai, Shanghai, China
                  Shanghai Pulmonary Hospital
                Jul 20, 2023